Mun-Ock Kim Selected Research

Mun-Ock Kim Research Topics

Disease

20	Neoplasms (Cancer) 01/2019 - 03/2008
13	Leukemia 06/2010 - 03/2008
5	Inflammation (Inflammations) 05/2022 - 10/2008
5	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 01/2018
5	Hepatocellular Carcinoma (Hepatoma) 05/2013 - 02/2010
2	Asthma (Bronchial Asthma) 01/2021 - 10/2008
1	Airway Obstruction (Choking) 03/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Epilepsy (Aura) 10/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Huntington Disease (Huntington's Disease) 10/2021
1	Parkinson Disease (Parkinson's Disease) 10/2021
1	Mucoepidermoid Carcinoma 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2018
1	Necrosis 01/2018
1	Lung Diseases (Lung Disease) 01/2018
1	Hyperlipidemias (Hyperlipidemia) 12/2017
1	Body Weight (Weight, Body) 12/2012
1	Breast Neoplasms (Breast Cancer) 10/2009
1	Neoplasm Metastasis (Metastasis) 02/2009
1	Respiratory Hypersensitivity 10/2008
1	Polyploidy 06/2008

Drug/Important Bio-Agent (IBA)

8	NF-kappa B (NF-kB)IBA 01/2018 - 06/2008
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 02/2009
7	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2010 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2008
4	Pharmaceutical PreparationsIBA 02/2022 - 10/2009
4	LigandsIBA 02/2018 - 04/2010
4	buteinIBA 02/2018 - 12/2009
3	SmokeIBA 05/2022 - 02/2022
3	LipopolysaccharidesIBA 05/2022 - 02/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2010 - 02/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2022 - 01/2022
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2018 - 06/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 02/2009
2	FlavonoidsIBA 02/2018 - 01/2018
2	LipidsIBA 01/2018 - 12/2017
2	muconomycin AIBA 09/2013 - 05/2013
2	sulforaphaneIBA 09/2010 - 02/2009
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2010 - 02/2009
2	Caspase 3 (Caspase-3)IBA 06/2010 - 08/2008
2	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 06/2008
2	GossypolIBA 10/2008 - 06/2008
2	platycodin DIBA 06/2008 - 03/2008
1	ginsenoside M1IBA 05/2022
1	phorbolIBA 05/2022
1	Phosphotransferases (Kinase)IBA 03/2022
1	daphnodorin CIBA 02/2022
1	ChitinasesIBA 01/2022
1	HydrolasesIBA 01/2022
1	kasugamycinIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 10/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	derroneIBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2018
1	GlycosidesIBA 02/2018
1	piscroside CIBA 02/2018
1	IridoidsIBA 02/2018
1	Therapeutic UsesIBA 02/2018
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2018
1	fisetinIBA 01/2018
1	InterleukinsIBA 01/2018
1	Acridine OrangeIBA 07/2015
1	1,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA 07/2015
1	TrichothecenesIBA 09/2013
1	CholesterolIBA 12/2012
1	LDL CholesterolIBA 12/2012
1	HDL CholesterolIBA 12/2012
1	Triglycerides (Triacylglycerol)IBA 12/2012
1	isothiocyanic acidIBA 09/2010
1	Biological ProductsIBA 09/2010
1	beta-lapachoneIBA 06/2010
1	ethyl 2- amino- 6- bromo- 4- (1- cyano- 2- ethoxy- 2- oxoethyl)- 4H- chromene- 3- carboxylateIBA 06/2010
1	AntioxidantsIBA 06/2010
1	JNK Mitogen-Activated Protein KinasesIBA 06/2010
1	beta-iononeIBA 04/2010
1	Carotenoids (Carotene)IBA 04/2010
1	Transcription Factors (Transcription Factor)IBA 02/2010
1	Rosmarinic AcidIBA 02/2010
1	RibonucleoproteinsIBA 12/2009
1	PolyphenolsIBA 12/2009
1	Gefitinib (Iressa)FDA Link 10/2009
1	Growth Factor ReceptorsIBA 10/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2009
1	Cyclin D1IBA 02/2009
1	CaspasesIBA 02/2009
1	Matrix Metalloproteinases (MMPs)IBA 02/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2008
1	Methacholine Chloride (Methacholine)FDA Link 10/2008
1	CytokinesIBA 10/2008
1	CurcuminIBA 10/2008
1	OvalbuminIBA 10/2008
1	AnnexinsIBA 08/2008
1	gamma-sitosterol (beta-sitosterol)IBA 06/2008
1	TriterpenesIBA 06/2008

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 06/2008 - 03/2008
2	Therapeutics 02/2010 - 10/2008
1	Intranasal Administration 05/2022